Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colonic Neoplasms × Exercise × Clear all

Phase

Phase NA 10 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 8 Breast Neoplasms 6 Neoplasms 4 Recurrence 2 Fatigue 2 Body Weight 2 Weight Loss 1 Warts 1 Vomiting 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Nausea 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Insulin Resistance 1 Head and Neck Neoplasms 1 Dementia 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Asthenia 1 Anomia 1 Alzheimer Disease 1

Interventions

Fluorouracil 57 Leucovorin 56 Oxaliplatin 38 Irinotecan 25 Folfox protocol 19 Capecitabine 18 Bevacizumab 17 Cetuximab 12 Chemotherapy, Adjuvant 11 Aspirin 6 Laparoscopy 5 Celecoxib 5 XELOX 4 dehydroftorafur 3 Panitumumab 3 Observation 3 Levamisole 3 Floxuridine 3 pertuzumab 2 encorafenib 2 atezolizumab 2 Trastuzumab 2 Tegafur 2 Standard of Care 2 Octreotide 2 Occult Blood 2 Nivolumab 2 Neoadjuvant Therapy 2 Mitomycin 2 Immunoglobulin G 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04488159 2024-09-20

iMAGINE

Medical University of Vienna

Phase 3 Withdrawn

Gastrointestinal

Colonic Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡